Rule No.: RULE TITLE
6A-6.0251: Use of Epinephrine Auto-Injectors.
PURPOSE AND EFFECT: The purpose and effect of this rule development is to address self-administration of medication by students enrolled in the public school system.
SUBJECT AREA TO BE ADDRESSED: The self-administration of pancreatic enzyme medication by students with cystic fibrosis, as well as self-management and care of students with diabetes, and the use of inhalers by students with asthma.
SPECIFIC AUTHORITY: 1002.20(3) FS.
LAW IMPLEMENTED: 1002.20(3) FS.
IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE HELD AT THE DATE, TIME AND PLACE SHOWN BELOW:
TIME AND DATE: September 28, 2010, 9:00 a.m. – 3:00 p.m.
PLACE: Department of Education, 325 West Gaines Street, Room 1721/25, Turlington Building, Tallahassee, Florida 32399
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Bambi J. Lockman, Chief, Bureau of Exceptional Education and Student Services, 325 West Gaines Street, Suite 614, Tallahassee, Florida 32399; (850)245-0475. To request a rule development workshop, please contact: Lynn Abbott, Agency Clerk, Department of Education, (850)245-9661 or e-mail lynn.abbott@fldoe.org or go to https://app1.fldoe.org/rules/default.aspx

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS NOT AVAILABLE.